Cargando…
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
SIMPLE SUMMARY: Poorly differentiated thyroid cancer is a rare subtype of thyroid cancer. The course of this disease can vary substantially. Treatment options consist of surgery and radioactive iodine therapy, if possible, and in tyrosine kinase inhibitors for patients where this is not possible. Th...
Autores principales: | Kersting, David, Seifert, Robert, Kessler, Lukas, Herrmann, Ken, Theurer, Sarah, Brandenburg, Tim, Dralle, Henning, Weber, Frank, Umutlu, Lale, Führer-Sakel, Dagmar, Görges, Rainer, Rischpler, Christoph, Weber, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038667/ https://www.ncbi.nlm.nih.gov/pubmed/33917322 http://dx.doi.org/10.3390/cancers13071728 |
Ejemplares similares
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
por: Weber, Manuel, et al.
Publicado: (2022) -
DLL3 (delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomas
por: Ingenwerth, M, et al.
Publicado: (2021) -
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma – Lessons From Individual Cases With Long-Term Follow-Up
por: Brandenburg, Tim, et al.
Publicado: (2021) -
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension
por: Weber, Manuel, et al.
Publicado: (2021) -
Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
por: Weber, Manuel, et al.
Publicado: (2021)